Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02884765
Other study ID # RP_BCFx_1.0
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 2017
Est. completion date December 2023

Study information

Verified date March 2024
Source AO Innovation Translation Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Prospective data will be collected in approximately 250 patients sustaining BCFx with or without any additional fracture(s) of the symphysis. Patients will be followed according to the standard (routine) at approximately 6 weeks and 3 months after the treatment. Data collection will include fracture details (i.e. classification, mechanism of injury), treatment details, functional and patient-reported outcomes, and anticipated or procedure-related adverse events (i.e. complications).


Description:

Fractures of the condyles occur in around one third of patients sustaining a mandibular fracture. Bilateral fractures are reported in around one fifth to one third of all fractures of the mandibular condyles and are often combined with other fractures of the mandible or facial skeleton. The treatment of condylar fractures, and in particular of bilateral condylar fractures (BCFx), is complex due to many different fracture patterns, surgeon's preferences, local constraints of the health care system and patient characteristics. Briefly, BCFx can be treated using either closed treatment (CTx) (e.g. intermaxillary fixation [IMF] and/or functional therapy) or surgical treatment (i.e. open reduction and internal fixation [ORIF]) in both fractures, or a combination of closed treatment and ORIF. The relationship of these treatments with the final outcome remains elusive, since the available literature does not report specific data for patients sustaining BCFx and has ignored or inadequately reported patient-reported outcomes. Consequently there is a lack of clinical evidence to assist the decision-making process. Therefore, the purpose of this registry is to collect data in a standardized manner regarding the treatment, the clinical and the patient-oriented outcomes, and the complications of BCFx.


Recruitment information / eligibility

Status Completed
Enrollment 227
Est. completion date December 2023
Est. primary completion date March 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - Age 18 to 90 years at the time of the fracture - Diagnosis of bilateral condylar fracture of the mandible with or without a concomitant fracture of the symphysis - Dentition: Patients must have enough maxillary and mandibular teeth present to identify proper occlusion Exclusion Criteria: - Unilateral condylar fracture - Additional maxillary fracture(s) - Polytrauma (i.e. life threatening condition) - Patients being treated with antiresorptive drugs at the time of inclusion or during their participation in the registry - Pregnancy - Prisoner - Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present registry

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Non-surgical
Non-surgical treatment in both condylar fractures
Non-surgical / Surgical
Non-surgical treatment in one condylar fracture and surgical treatment of the contralateral fracture
Surgical
Surgical treatment in both condylar fractures

Locations

Country Name City State
Finland Helsinki University Hospital Helsinki
Germany Universitaetsklinikum Eppendorf Hamburg
Germany LMU - Klinikum der Universität München Munich
Malaysia Hospital Sungai Buloh Sungai Buloh
Mexico Hospital General de Especialidades Campeche
Mexico Hospital Trauma y Ortopedia Lomas Verdes Mexico City
Netherlands Eramus MC Rotterdam
Pakistan Mayo Hospital Lahore Lahore
Slovenia University Medical Centre Ljubljana Ljubljana
South Africa King Edward VIII Hospital Durban
Spain Hospital Vall d' Hebron Barcelona Catalonia
Spain 12 de Octubre University Hospital Madrid
Spain University Hospital La Paz de Madrid Madrid
Switzerland Universitätsspital Basel Basel
Switzerland Universitätsspital Zürich Zürich
Taiwan National Cheng Kung University Hospital Tainan
Ukraine Lviv Regional Clinical Hospital Lviv
United States University of Kentucky Chandler Medical Center Lexington Kentucky
United States University of Louisville Louisville Kentucky
United States University of Texas Health Science Center at San Antonio San Antonio Texas
Uruguay Hospital Maciel de Montevideo Montevideo

Sponsors (2)

Lead Sponsor Collaborator
AO Clinical Investigation and Publishing Documentation AOCMF

Countries where clinical trial is conducted

United States,  Uruguay,  Finland,  Germany,  Malaysia,  Mexico,  Netherlands,  Pakistan,  Slovenia,  South Africa,  Spain,  Switzerland,  Taiwan,  Ukraine, 

Outcome

Type Measure Description Time frame Safety issue
Other Mandible dysfunction (Helkimo Index) 6 weeks / 3 months
Other Clinical evaluation of the occlusion status Normal for the patient
Abnormal for the patient (anterior open bite / crossbite / lateral open bite in the premolar area / lateral open bite in the mola area)
6 weeks / 3 months
Other Pain (numeric rating scale) 6 weeks / 3 months
Primary Mandibular movements (mobility index) Interincisal opening/maximal opening is defined as distance in millimeters between the edges of the incisors of the mandibular and the maxillary bone.
Lateral movements: With the mandible slightly open, it is defined as the distance in millimeters from the labioincisal embrasure between the central incisors to the labioincisal embrasure of the mandibular incisors
Protrusive movement: With the mandible slightly open, it is defined as the distance in millimeters between the incisal edges of the maxillary central incisor to the mandibular central incisor.
Depending on the score, the mobility index will be calculated as follow:
0 points: normal mandibular mobility
1 - 4 points: slightly impaired mobility
5 - 20 points: severely impaired mobility
3 months